Lower human immunodeficiency virus (HIV) type 2 viral load reflects the difference in pathogenicity of HIV-1 and HIV-2 - PubMed

Affiliations

• PMID: 10479138
• DOI: 10.1086/315010

Comparative Study

Lower human immunodeficiency virus (HIV) type 2 viral load reflects the difference in pathogenicity of HIV-1 and HIV-2

S J Popper et al. J Infect Dis. 1999 Oct.

Abstract

Human immunodeficiency virus type 2 (HIV-2) is less pathogenic than HIV type 1 (HIV-1), but the mechanisms underlying this difference have not been defined. We developed an internally controlled quantitative reverse transcriptase-polymerase chain reaction to measure HIV-2 viral load and determined levels of plasma virus in a cohort of registered commercial sex workers in Dakar, Senegal. The assay has a lower limit of detection of 100 copies/mL and is linear over 4 logs. HIV-2 viral RNA was detectable in 56% of all samples tested; the median load was 141 copies/mL. Levels of viral RNA in the plasma were inversely related to CD4+ cell counts. HIV-2 and HIV-1 viral loads were compared among the seroincident women in the cohort; the median viral load was 30x lower in the HIV-2-infected women (P<.001, Wilcoxon rank sum test), irrespective of the length of time infected. This suggests that plasma viremia is linked to the differences in the pathogenicity of the 2 viruses.

Similar articles

• Plasma viral load in HIV-1 and HIV-2 singly and dually infected individuals in Guinea-Bissau, West Africa: significantly lower plasma virus set point in HIV-2 infection than in HIV-1 infection.

  Andersson S, Norrgren H, da Silva Z, Biague A, Bamba S, Kwok S, Christopherson C, Biberfeld G, Albert J. Andersson S, et al. Arch Intern Med. 2000 Nov 27;160(21):3286-93. doi: 10.1001/archinte.160.21.3286. Arch Intern Med. 2000. PMID: 11088091

• Lower levels of HIV RNA in semen in HIV-2 compared with HIV-1 infection: implications for differences in transmission.

  Gottlieb GS, Hawes SE, Agne HD, Stern JE, Critchlow CW, Kiviat NB, Sow PS. Gottlieb GS, et al. AIDS. 2006 Apr 4;20(6):895-900. doi: 10.1097/01.aids.0000218554.59531.80. AIDS. 2006. PMID: 16549974 Free PMC article.

• Initial plasma HIV-1 RNA levels and progression to AIDS in women and men.

  Sterling TR, Vlahov D, Astemborski J, Hoover DR, Margolick JB, Quinn TC. Sterling TR, et al. N Engl J Med. 2001 Mar 8;344(10):720-5. doi: 10.1056/NEJM200103083441003. N Engl J Med. 2001. PMID: 11236775

• [Consensus document of Gesida and Spanish Secretariat for the National Plan on AIDS (SPNS) regarding combined antiretroviral treatment in adults infected by the human immunodeficiency virus (January 2012)].

  Panel de expertos de Gesida y Plan Nacional sobre el Sida. Panel de expertos de Gesida y Plan Nacional sobre el Sida. Enferm Infecc Microbiol Clin. 2012 Jun;30(6):e1-89. doi: 10.1016/j.eimc.2012.03.006. Epub 2012 May 23. Enferm Infecc Microbiol Clin. 2012. PMID: 22633764 Spanish.

• [Diagnostic tests: Human immunodeficiency virus type 1, type 2 (HIV-1, HIV 2)].

  Fujii T. Fujii T. Nihon Rinsho. 2005 Jul;63 Suppl 7:434-7. Nihon Rinsho. 2005. PMID: 16111295 Review. Japanese. No abstract available.

Cited by

• Low plasma human immunodeficiency virus type 2 viral load is independent of proviral load: low virus production in vivo.

  Popper SJ, Sarr AD, Guèye-Ndiaye A, Mboup S, Essex ME, Kanki PJ. Popper SJ, et al. J Virol. 2000 Feb;74(3):1554-7. doi: 10.1128/jvi.74.3.1554-1557.2000. J Virol. 2000. PMID: 10627569 Free PMC article.

• Plasma RNA viral load in human immunodeficiency virus type 2 subtype A and subtype B infections.

  Damond F, Gueudin M, Pueyo S, Farfara I, Robertson DL, Descamps D, Chène G, Matheron S, Campa P, Brun-Vézinet F, Simon F. Damond F, et al. J Clin Microbiol. 2002 Oct;40(10):3654-9. doi: 10.1128/JCM.40.10.3654-3659.2002. J Clin Microbiol. 2002. PMID: 12354861 Free PMC article.

• The HIV-2 proviral landscape is dominated by defective proviruses.

  Koofhethile CK, Gao C, Chang C, Lian X, Shapiro R, Yu XG, Lichterfeld M, Kanki PJ. Koofhethile CK, et al. AIDS. 2024 Mar 1;38(3):309-316. doi: 10.1097/QAD.0000000000003776. Epub 2023 Nov 22. AIDS. 2024. PMID: 37916471 Free PMC article.

• Human immunodeficiency virus (HIV)-2-specific T lymphocyte proliferative responses in HIV-2-infected and in HIV-2-exposed but uninfected individuals in Guinea-Bissau.

  Andersson S, Larsen O, Da Silva Z, Linder H, Norrgren H, Dias F, Thorstensson R, Aaby P, Biberfeld G. Andersson S, et al. Clin Exp Immunol. 2005 Mar;139(3):483-9. doi: 10.1111/j.1365-2249.2005.02723.x. Clin Exp Immunol. 2005. PMID: 15730394 Free PMC article.

• Direct evidence of lower viral replication rates in vivo in human immunodeficiency virus type 2 (HIV-2) infection than in HIV-1 infection.

  MacNeil A, Sarr AD, Sankalé JL, Meloni ST, Mboup S, Kanki P. MacNeil A, et al. J Virol. 2007 May;81(10):5325-30. doi: 10.1128/JVI.02625-06. Epub 2007 Feb 28. J Virol. 2007. PMID: 17329334 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Ovid Technologies, Inc.
  • Silverchair Information Systems

• Other Literature Sources

  • The Lens - Patent Citations Database

• Medical

  • MedlinePlus Health Information

• Research Materials

  • NCI CPTC Antibody Characterization Program